LONDON, May 17, 2017 /PRNewswire/ --

Epoetin Alfa, Epoetin Beta, Darbepoetin Alfa, Biosimilars, EPO API Manufacturing

The global erythropoietin market is expected to grow at a CAGR of 7.8% in the first half of the forecast period and CAGR of 4.8% in the second half of the forecast period. The market is estimated at $7.9bn in 2016 and $16.5bn in 2027.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 164-page report you will receive 84 tables and 93 figures - all unavailable elsewhere.

The 164-page report provides clear detailed insight into the global erythropoietin market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope 

• Global Erythropoietin Market forecasts from 2017-2027

• Revenue forecasts of global erythropoietin market, segmented by product type:
- Epoetin Alfa
- Epoetin Beta
- Darbepoetin Alfa
- Biosimilars
- Others

This section also discusses the leading drugs as well as SWOT analysis of each submarket.

• Revenue forecasts of global erythropoietin market, segmented by application:
- Anemia (Cancer and HIV Treatment)
- Kidney Disorders (ESRD and Dialysis)
- Others

• Revenue forecasts of global erythropoietin API manufacturing market, segmented by contract manufacturing and in-house manufacturing

• Erythropoietin Leading Regional Market forecasts from 2017-2027 covering North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.

Forecast for each regional market is further segmented by product type, application and country:
- US
- Canada
- UK
- Germany
- France
- Spain
- Italy
- Rest of Europe
- China
- Japan
- India
- Rest of Asia-Pacific
- Brazil
- Mexico
- Rest of Latin America
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa

• Assessment of selected leading companies that hold major market shares in the erythropoietin market:
- Amgen
- Johnson & Johnson
- Roche
- Biocon
- 3SBio
- Pfizer
- Kyowa Hakko Kirin Co Ltd
- LG Life Sciences Limited
- Intas Pharmaceuticals Ltd
- Novartis AG

Visiongain's study is intended for anyone requiring commercial analyses for the erythropoietin market. You find data, trends and predictions.

Buy our report today Global Erythropoietin Market Forecast 2017-2027: Epoetin Alfa, Epoetin Beta, Darbepoetin Alfa, Biosimilars, EPO API Manufacturing.

To request a report overview of this report please email Sara Peerun at sara.peerun@visiongain.com or call Tel: +44-(0)-20-7336-6100

Or click on: https://www.visiongain.com/Report/1858/Global-Erythropoietin-Market-Forecast-2017-2027

The companies mentioned are:

3SBio Inc.
Accord Healthcare Limited
Actavis
Akebia Therapeutics
Amgen
Astellas Pharma Inc
AstraZeneca
Bio Sidus SA
Biocon Ltd
Casa Marzam
Casa Saba
Chugai Pharmaceutical
Claes-Göran Östenson
Corvidia Therapeutics
DaVita Inc
Dr. Reddy's Laboratories
FibroGen
First Shanghai Investments Limited
Fresenius Medical Care North America (FMCNA)
Galenica
Germans Trias i Pujol Hospital
GlaxoSmithKline
H. Lundbeck A/S
Hoffmann-La Roche
Hospira
Janssen Biotech
Japan Chemical Research Pharmaceuticals Co., Ltd.
Johnson & Johnson
Kissei pharmaceuticals
Kosin University Gospel Hospital
Kyowa Hakko Kirin Co Ltd
LG Life Sciences Limited
NADRO
NovaQuest Co-Investment Fund I, L.P.
Novartis Institutes for BioMedical Research (NIBR)
Novartis Pharmaceuticals
NOXXON Pharma AG
Pfizer
Proveedora de Medicamentos
RPG Life Sciences
Sandoz
Sirton Pharma
Stada
Stem Cell Therapeutics Corp.
Teva Pharmaceutical Industries Ltd.
UBI Pharma Inc.
Vifor Pharma

List of Organizations Mentioned in the Report
Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM)
Centers of Disease Control and Preventions
China's Ministry of Health (MOH)
Committee for Medicinal Products for Human Use (CHMP)
Department of Health & Family Welfare of Karnataka
Deutsches Ärzteblatt
EMA
European Commission (EC)
FDA
Indian Council of Medical Research (ICMR)
International Agency for Research on Cancer (IARC)
Ministry of Health, Malaysia
National Cancer Institute
National Center for Biotechnology Information
National Kidney Foundation
UK Nephrology - Renal Association
World Cancer Research Fund International
World Health Organizations

To see a report overview please email Sara Peerun on sara.peerun@visiongain.com

SOURCE Visiongain Ltd